Investment Analysts’ downgrades for Sunday, November 1st:
Amphastar Pharmaceuticals (NASDAQ:AMPH) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
Auna (NYSE:AUNA) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
CACI International (NYSE:CACI) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Clean Harbors (NYSE:CLH) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
Conduent (NASDAQ:CNDT) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating.
Trump Media & Technology Group (NASDAQ:DJT) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating.
Ecovyst (NYSE:ECVT) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Exelixis (NASDAQ:EXEL) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
Herbalife (NYSE:HLF) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Harmony Gold Mining (NYSE:HMY) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Robinhood Markets (NASDAQ:HOOD) was downgraded by analysts at Wall Street Zen from a hold rating to a strong sell rating.
HireQuest (NASDAQ:HQI) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
Humana (NYSE:HUM) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Kroger (NYSE:KR) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Keros Therapeutics (NASDAQ:KROS) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating.
Lionsgate Studios (NYSE:LION) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Logitech International (NASDAQ:LOGI) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Manhattan Associates (NASDAQ:MANH) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Malibu Boats (NASDAQ:MBUU) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
enVVeno Medical (NASDAQ:NVNO) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.
Pitney Bowes (NYSE:PBI) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
PRA Group (NASDAQ:PRAA) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
StandardAero (NYSE:SARO) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
SEA (NYSE:SE) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Sezzle (NASDAQ:SEZL) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Selective Insurance Group (NASDAQ:SIGI) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Similarweb (NYSE:SMWB) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
Entrada Therapeutics (NASDAQ:TRDA) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.
TTM Technologies (NASDAQ:TTMI) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
Tvardi Therapeutics (NASDAQ:TVRD) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating.
TWFG (NASDAQ:TWFG) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Universal Electronics (NASDAQ:UEIC) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.
Valmont Industries (NYSE:VMI) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Voyager Technologies (NYSE:VOYG) was downgraded by analysts at Wall Street Zen from a sell rating to a strong sell rating.
Woori Bank (NYSE:WF) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.
Receive News & Ratings for Amphastar Pharmaceuticals Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amphastar Pharmaceuticals Inc and related companies with MarketBeat.com's FREE daily email newsletter.
